Ansa Biotechnologies Raises $71.5 Million in Oversubscribed Series C Round to Scale Guaranteed DNA Synthesis

[#item_full_content]EMERYVILLE, Calif.–(BUSINESS WIRE)– #Biotechnology–Ansa Biotechnologies announced the closing of a $71.5 million oversubscribed Series C financing.

Leave a Reply

Your email address will not be published. Required fields are marked *